Hemolytic uremic syndrome. Treatment of secondary glomerulopathy;Sindrome uremico hemolitico tratamiento de la glomerupatia secundaria

Medicina

Volumn 65, Issue 6, 2005, Pages 528-532

  Caletti, María Gracia ^a   Gallo, Guillermo ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Chronic renal failure; Hemolytic uremic syndrome; iACE; Proteinuria; Treatment

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; GLOMERULOPATHY; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERTENSION; PROTEIN INTAKE; PROTEINURIA; REVIEW; SODIUM RESTRICTION; ADOLESCENT; ADULT; ARTICLE; BIOPSY; CHILD; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; CHILD; DIET, SODIUM-RESTRICTED; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; PROTEINURIA;

EID: 31144453277     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Gianantonio CA, Vitacco M, Mendilaharzu F, Rutty A, Mendilaharzu J. The hemolytic uremic syndrome. J Pediatr 1964; 4: 478-91.
2. Trompeter RS, Schwartz R, Chantler C, et al. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child 1983; 58: 101-5.
3. Karmali M, Petric M, Lim C. The association between idiopathic UHS and infection by verotoxin-producing E. coli. J Infect Dis 1985; 160: 469-72.
4. Rivas M, Balbi L, Miliwebsky ES, et al. Síndrome Urémico Hemolítico en niños de Mendoza, Argentina. Asociación con la infección por Escherichia coli productor de Toxina Shiga. Medicina (Buenos Aires) 1998; 58: 1-7.
5. Rivas M, Voyer L, Quadri B, et al. Verotoxin-producing E. coli infection in family members with HUS. Medicina (Buenos Aires) 1996; 56: 119-25.
6. Mendilaharzu F, Caletti MG, Gómez EM. Epidemiology of Chronic Renal Failure (CRE). Period 1987-1989 Collaboratory Study of ALANEPE, Report of Argentina. Ped Res 1992; Vol 32 N6 Abstract N27: 741.
7. Repetto HA. Follow-up of hemolytic-uremic syndrome in Argentina, In: Trompeter RS, Moake JL, Kaplan BS (eds) Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic purpura, N. York: Dekker, 1992 p 89-96.
8. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM: Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ 1991; 303: 489-92.
9. Kelles A, Van Dyck M, Proesmans W. Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr 1994; 153: 38-42.
10. Siegler RL, Pavia AT, Christofferson RD, Milligan MK, A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994; 94: 35-40.
11. Spizirri FD, Rhaman RC, Bibiloni N, Ruscasso JD, Amoreo OR. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 1997; 11: 156-60.
12. Milford DV, White RHR, Taylor CM. Pronostic significance of proteinuria one year after onset of diarrhea-associated hemolytic-uremic syndrome. J Pediatr 1991; 118: 191-4.
13. Gianantonio C, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The Hemolytic-Uremic Syndrome. Nephron 1973; 11: 174-92.
14. Caletti MG, Gallo G, Gianantonio CA. Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol 1996; 10: 687-92.
15. Moghal NE, Ferreira MAS, Howie AJ, Milford DV, Raafat F, FRCPath, Taylor CM. The late histologic findings in diarrhea-associated hemolytic uremic syndrome. J Pediatr 1998; 133: 220-3.
16. D'agati V. The many masks of focal segmental glomerulosclerosis. Nephrol Forum. Kidney Int 1994; 46: 1223-41.
17. Hostetter TH, Olson JL, Rennke HG, Venkatatachelam MA, Brenner BM. Hiperfiltration in remanent nephrons: a potential adverse response to renal ablation. Am J Physiol 1981; 241: F85-F93.
18. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982; 22: 112-26.
19. Brenner BM. Hemodinamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Inter 1983; 23: 647-55.
20. Fogo A, Kon V. Pathophysiology of progressive renal disease. In: Martin Barratt T, Avner ED, Harmon WE (eds). Pediatric Nephrology. 4th ed. Baltimore, 1999; p 1183-96.
21. Gopal Krishna G, Newell G, et al. Protein-induced glomerular hyperfiltration: role of hormonal factors. Kidney Int 1988; 33: 578-83.
22. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. The New Engl J Med 1998; 20: 1448-56.
23. Bouissou Soares CM, Oliveira EA, Diniz JSS, Lima EM, Vasconcelos MM, Oliveira GR: Predictive factors of progression of chronic renal insufficiency: a multivariate analysis. Pediatr Nephrol 2003; 18: 371-7.
24. Rugiú C, Oldrizzi L, Lupo A, et al. Clinical features of patients with solitary kidneys. Nephron 1986; 43: 10-5.
25. Cotran RS. Nephrology forum: glomerulosclerosis in reflux nephropathy. Kidney Int 1982; 21: 528-34.
26. Breyer JA, Bain RP, Evans JK, et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 1996; 50: 1651-8.
27. Ruggenenti P, Perna A, Mosconi L, et al. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. Kidney Int Suppl 1997; 63: S-54-S-57.
28. George GRP, Hickman RO, Stricker GF. Infantile nephrotic syndrome. Clin Nephrol 1976; 5: 20-4.
29. Aperia A, Brobenger O, Wilton P. Renal function adaptation in the remanent kidney in patientes with renal agenesis and in patients nephrectomized in childhood. Acta Paediatr Scand 1978; 67: 611-5.
30. Perelstein EM, Grunfeld BG, Simsolo RB, Jiménez MI, Gianantonio CA. Renal functional reserve compared in haemolytic uraemic syndrome and single kidney. Arch Dis Child 1990; 65: 728-31.
31. Tufró A, Arizurrieta E, Repetto H. Renal functional reserve in children with a previous episode of hemolytic-uremic syndrome. Pediatr Nephrol 1991; 5:184-8.
32. Oldrizzi L, Rugiú C, Valvo E, et al. Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. Kidney Int 1985; 27: 553-7.
33. Giordano C. Protein restriction in chronic renal failure. Kidney Int 1982; 22: 401-8.
34. Mann JFE, Reisch C, Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. Kidney Int 1990; 38: 590-4.
35. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 1996; 156: 286-9.
36. Maschio G, Alberti D, Janin J, et al. (and the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group). Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 9939-45.
37. Caletti MG, Lejarraga H, Kelmansky D, Missoni M. Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome. Pediatr Nephrol 2004; 19: 1148-52.
38. Committee on Dietary Allowances. Recommended dietary allowances, Washington D.C.: National Academy of Science, 1989.
39. National Heart Lung and Blood Institute's Task Force Bethesda, Maryland. Blood pressure control in children. Pediatrics 1984; 79: 1-25.